Skip to main content

Citadel Initiates Human Genome Sciences With Add Rating, $25 PT

Joe Young

August 08, 2011 6:02am Comments

Citadel Securities has initiated coverage on Human Genome Sciences (NASDAQ: HGSI) with an Add rating and $25 price target.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: citadel securities Price Target Initiation Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

View the Latest Analytics Ratings

1	LLY: Eli Lilly Co. Q2 FY2025 Earnings Transcript
2	RL, AVGO: Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's...
3	TC, LEGH: Earnings Scheduled For August 7, 2025
4	Another Fed Official Backs A Rate Cut—Goldman Sees Trouble...
5	MCD, CCEP: Wall Street Recovers, Apple Rallies 6% On $100-Billi...
6	NVO, LLY: Eli Lilly's Closely Watched Obesity Pil...
7	XYZ, LLY: Nasdaq Surges Over 1% Amid Jump In A...

1	$BTC, $XRP: XRP Surges 8% As Ripple-SEC Case Concludes — Traders Ancitipate Mult...
2	The Dollar Faces A 'Wile E. Coyote Moment' As Stagflation Lo...
3	GOOG, GOOGL: Apple's 'BlackBerry Moment' Looms Without Th...
4	Is Warren Buffett About To Dump The Highest-Yielding Divide...
5	AMCX: AMC Networks Touts Streaming And Content Licensing As K...
6	Stablecoins Under Fire In China, While US Enacts A Fede...
7	PANW, AAPL: Apple, Palo Alto Networks And An Energy Stock...